The overexpression of SREBP-2 in APP/PS1 mice has been reported to exacerbate amyloid pathology and neuronal death, accompanied by a decline in cognitive abilities, while the inhibition of SREBP-2 alleviates amyloid burden in AD mice [181, 182]. This evidence concerns the gene APP and amyloidosis.